Literature DB >> 31683334

[Empowerment and Stigma as Mediator Variables Between Illness Severity and Quality of Life of Patients with Affective Disorders].

Maria Panzirsch1, Karel Frasch1,2, Reinhold Kilian2.   

Abstract

OBJECTIVE: The investigation of mediating effects of empowerment and stigmatization on the association between depressive symptoms and subjective quality of life in patients with affective disorders.
METHOD: Depressive Symptoms (BDI-II), internalized and perceived stigmatization (ISMI; PDDQ), empowerment (EPAS) and subjective quality of life (WHOQOL-BREF) were assessed in 37 patients with affective disorders (F31 - F33; ICD-10), age 18+ in inpatient, day hospital or outpatient psychiatric treatment. Data analyses were conducted by means of path-analysis.
RESULTS: Empowerment and in low proportion internalized and perceived stigma turned out to be mediating variables between the severity of depression and subjective quality of life. 57 % of the variance of the subjective quality of life could be explained by the path model.
CONCLUSION: Empowerment has meaningful influence mediating between depression and subjective quality of life. In order to improve the quality of life of patients with an affective disorder, strategies for increasing empowerment are to be integrated into treatment. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 31683334     DOI: 10.1055/a-1002-0508

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  1 in total

1.  Effectiveness and cost-effectiveness of a community-based mental health care programme (GBV) for people with severe mental illness in Germany: study protocol for a randomised controlled trial.

Authors:  Annabel Sandra Mueller-Stierlin; Friedrich Meixner; Anne Kohlmann; Mara Schumacher; Anke Hänsel; Melanie Pouwels; Nicole Bias; Sabrina Hartl; Jessica Reichstein; Elke Prestin; Nils Greve; Thomas Becker; Reinhold Kilian
Journal:  Trials       Date:  2020-06-30       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.